Serum angiotensin I-converting enzyme activity in premature and full-term infants

Area of Science:

• Biochemistry
• Neonatology
• Physiology

Background:

• Serum angiotensin I-converting enzyme activity (SCEA) plays a crucial role in the renin-angiotensin system.
• Understanding SCEA levels in newborns is important for assessing physiological development.

Purpose of the Study:

• To investigate and compare serum angiotensin I-converting enzyme activity (SCEA) in premature newborns, full-term newborns, and healthy adults.
• To determine if there is a correlation between SCEA values and gestational age in newborns.

Main Methods:

• Serum samples were collected from 15 healthy premature newborns (30-36 weeks gestation), 14 healthy full-term newborns (37-41 weeks gestation), and 16 healthy adults.
• Serum angiotensin I-converting enzyme activity (SCEA) was measured using a standard biochemical assay.

Main Results:

• Mean SCEA values were 23.3 +/- 1.3 nM/min/ml in premature newborns, 24.4 +/- 1.6 nM/min/ml in full-term newborns, and 23.2 +/- 1.7 nM/min/ml in adults.
• No significant differences in SCEA were observed among the three groups.
• No correlation was found between SCEA values and gestational age in the newborn groups.

Conclusions:

• Serum angiotensin I-converting enzyme activity (SCEA) is established early in development and remains consistent through infancy and adulthood.
• Gestational age does not appear to influence SCEA levels in healthy newborns.
• These findings contribute to the understanding of the renin-angiotensin system's maturation.